Transforming Autism Spectrum Disorder Management Through Artificial Intelligence

Abstract:: Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental disorder characterized by complex pathophysiology involving social communication impairments, restricted interests, and repetitive behavior. Rising worldwide prevalence and symptom variability complicate accurate diagnosis and individualized treatment, posing significant challenges for clinicians. New evidence points towards multifactorial interactions—such as polygenic risk, environmental pollutants, and epigenetic deregulation—as major contributors to the etiology of ASD. This article intends to raise awareness of the potential of utilizing Artificial Intelligence (AI) to transform ASD diagnosis and treatment. By integrating machine learning techniques with multimodal neuroimaging, genetic, and behavioral data, we introduce AI-driven diagnostic systems for precise and early identification of ASD. We also discuss AI-supported customized treatments, including personalized behavioral and targeted pharmacological interventions. Our work highlights the promise that AI holds for reshaping the landscape of ASD care by providing timely and optimal interventions that improve outcomes for individuals with ASD and their families.

Authors

Institutions

Publication Details

Journal
Current Psychopharmacologye
Published
2026-03-13
DOI
https://doi.org/10.2174/0122115560427395251210111715
Primary Topic
Autism Spectrum Disorder Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transforming Autism Spectrum Disorder Management Through Artificial Intelligence

Brijesh G. Taksande, Anil M. Pethe, Surendra Agrawal, Dilip Madia et al.
Current Psychopharmacologye
Autism Spectrum Disorder Research
article

Transforming Autism Spectrum Disorder Management Through Artificial Intelligence

Brijesh G. Taksande, Anil M. Pethe, Surendra Agrawal, Dilip Madia, Darshan Telange, Hellen Y. Dzoagbe
article en

Abstract

Abstract:: Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental disorder characterized by complex pathophysiology involving social communication impairments, restricted interests, and repetitive behavior. Rising worldwide prevalence and symptom variability complicate accurate diagnosis and individualized treatment, posing significant challenges for clinicians. New evidence points towards multifactorial interactions—such as polygenic risk, environmental pollutants, and epigenetic deregulation—as major contributors to the etiology of ASD. This article intends to raise awareness of the potential of utilizing Artificial Intelligence (AI) to transform ASD diagnosis and treatment. By integrating machine learning techniques with multimodal neuroimaging, genetic, and behavioral data, we introduce AI-driven diagnostic systems for precise and early identification of ASD. We also discuss AI-supported customized treatments, including personalized behavioral and targeted pharmacological interventions. Our work highlights the promise that AI holds for reshaping the landscape of ASD care by providing timely and optimal interventions that improve outcomes for individuals with ASD and their families.

Current PsychopharmacologyeVol. 14
Government Medical College (IN), Datta Meghe Institute of Higher Education and Research (IN)
Openalex Percentile: Top 26%
Autism Spectrum Disorder Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.